Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Alzheimer's disease, Parkinson's disease, type 2 diabetes similar at the molecular level

Alzheimer's disease, Parkinson's disease, type 2 diabetes, the human version of mad cow disease (Creutzfeldt-Jakob disease), and other degenerative diseases are more closely related at the molecular level than many scientists realized, an international team of researchers, including an ESRF researcher, report in the journal Nature.

8 May 2007

"Cup of joe" found to have more health benefits

According to a new study drinking coffee may offer protection from type 2 diabetes and some types of cancer.

7 May 2007

Phase III data on Safinamide in Parkinson's disease

Merck Serono S.A. has announced that Phase III data on safinamide, a new agent in Phase III development for the treatment of Parkinson's disease symptoms, were presented by Professor Fabrizio Stocchi at the American Academy of Neurology 59th Annual Meeting in Boston, Massachusetts, USA.

4 May 2007

CleveMed receives approval to market motor assessment system

Cleveland Medical Devices has received Food and Drug Administration (FDA) clearance to market Kinesia, a quantitative motor assessment system.

2 May 2007

Lawmakers have proposed 'witch's brew' of biotech bills

Lawmakers in recent months "have stirred up a witch's brew of initiatives that is cause for some concern -- not only for the biotech industry, but for all Americans," James Mullen, president and CEO of Biogen and chair of the Biotechnology Industry Organization, writes in a Wall Street Journal opinion piece.

1 May 2007

Virtual reality device helps multiple sclerosis patients walk

Technion-Israel Institute of Technology scientists have created a virtual reality device that combines auditory and visual feedback to improve walking speed and stride length in patients suffering from Multiple Sclerosis (MS) and Parkinson's disease.

1 May 2007

Moderate coffee drinking reduces many risks

Although the American Society for Nutrition's popular ,controversy session, at Experimental Biology 2007 focuses on the health effects of coffee drinking, panel chair Dr. James Coughlin, a toxicology/safety consultant at Coughlin & Associates, says that recent advances in epidemiologic and experimental knowledge have transformed many of the negative health myths about coffee drinking into validated health benefits.

1 May 2007

Alzheimer's, Parkinson's, type 2 diabetes are more closely related at the molecular level than scientists realized

Alzheimer's disease, Parkinson's disease, type 2 diabetes, the human version of mad cow disease, and other degenerative diseases are more closely related at the molecular level than scientists realized, a team reports this week in an advanced online publication of the journal Nature.

1 May 2007

Submission of NDA for Istradefylline(KW-6002), an investigational anti-Parkinson's disease drug

Kyowa Hakko Kogyo Co. has announced that Kyowa Pharmaceutical, Inc., its wholly owned U.S subsidiary, submitted on April 25, 2007 a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for Istradefylline(KW-6002), its investigational drug for Parkinson's disease.

30 Apr 2007

Identifying cardiorespiratory neurocircuitry involved in central command during exercise in humans

For almost one hundred years the brain's ,central command, system , whose charge includes controlling the body's cardiorespiratory response to exercise , has been pursued. Animal experiments and functional imaging studies have provided clues to the location of this system, but the underlying electrophysiological activity has never been measured.

30 Apr 2007

Scientists identify key mechanism for successfully transplanting tissue into the adult central nervous system

Scientists at the Schepens Eye Research Institute, an affiliate of Harvard Medical School, have identified a key mechanism for successfully transplanting tissue into the adult central nervous system.

27 Apr 2007

New Parkinson's Disease diagnostic test

While Florey researchers have also created a genetic test for Parkinson's Disease (PD) [10% of PD cases are caused by genetic factors], this new test has a broader application by screening for many different types of PD and monitoring treatment, as well as measuring the effectiveness of drugs being developed to treat the disease.

27 Apr 2007

Drugs that adjust dopamine levels in the brain greatly affect how people react to success and failure

In a first-of-its-kind study on humans, researchers measured how dopamine-related drugs affect the striatum, a part of the brain that is stimulated by rewards.

27 Apr 2007

Avicena files composition of matter patent application for treatment of Parkinson's disease

Avicena Group, Inc. has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office to cover potential treatments for Parkinson's disease, a progressive neurodegenerative disease.

27 Apr 2007

Humans should try to increase melatonin consumption through food

The Spanish Ageing Research Network (Red Nacional de Investigaci'n del Envejecimiento), funded by Carlos III Health Institute and headed by professor Dario Acuna Castroviejo, from the University of Granada, is very near to achieving one of today's Science greatest goals: allowing humans to age in the best possible health conditions.

25 Apr 2007

Resveratrol and red wine

Red wine is being widely touted for its health benefits, but not all red wines may act the same according to researchers at the University of Hertfordshire.

24 Apr 2007

New FDA audio broadcasts provide emerging drug safety information

The U.S. Food and Drug Administration (FDA) is alerting health care professionals and consumers to the availability of audio broadcasts that provide emerging drug safety information.

24 Apr 2007

NanoFrontiers: Visions for the Future of Nanotechnology

Controlling the properties and behavior of matter at the smallest scale, in effect, "domesticating atoms",can help to overcome some of the world's biggest challenges, concludes a new report on how diverse experts view the future of nanotechnology.

24 Apr 2007

Nanotechnology and biology for healing

Imagine a world where damaged organs in your body, kidneys, liver, heart, can be stimulated to heal themselves.

24 Apr 2007

Exercise reduces risk for Parkinson's disease

The risk of developing Parkinson's disease may be reduced with moderate to vigorous exercise or other recreational activities, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 , May 5, 2007.

24 Apr 2007